Hormone
insulin glargine Audio
[ in-suh-lin glar-jeen ]
Brand Names:
Basaglar; Lantus; Semglee; Soliqua; Toujeo
Effect:
Decreased Glycogenolysis; Decreased Lipolysis; Increased Glucose Transport into Cells; Increased Glycogenesis; Increased Lipogenesis; Increased Protein Synthesis
May Treat:
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Hyperglycemia
More Information:
ChemID; DrugBank; DailyMed; PDR
Definitions related to insulin glargine:
  • A drug used to control the amount of sugar in the blood of patients with diabetes. It is a form of the hormone insulin that is made in the laboratory. Insulin glargine controls blood sugar longer than insulin does. It is a type of therapeutic insulin.
    NCI Dictionary of Cancer Terms
    U.S. National Cancer Institute, 2021
  • A recombinant human insulin analog with long-acting, blood glucose-lowering activity. Insulin glargine, like regular types of human insulin, regulates glucose metabolism by binding to insulin receptors on muscle and fat cells, thereby facilitating the cellular uptake of glucose. This lowers blood glucose levels. At the same time, insulin glargine inhibits the liver's conversion of stored glycogen into glucose, which also contributes to lower blood glucose levels. Insulin glargine also inhibits lipolysis in adipose tissue, inhibits proteolysis, and enhances protein synthesis. (NCI05)
    NCI Thesaurus
    U.S. National Cancer Institute, 2021
  • A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS.
    NLM Medical Subject Headings
    U.S. National Library of Medicine, 2021
Try this search on: Farlex, Merriam-Webster, Oxford Dictionary, or Wordnik

This content should not be used in place of medically-reviewed decision support reference material or professional medical advice. Some terms may have alternate or updated definitions not reflected in this set. The definitions on this page should not be considered complete or up to date.